News

Extracranial Systemic Embolic Events in Patients with Nonvalvular Atrial Fibrillation: Incidence, Risk Factors, and Outcomes

06.08.20151506

Nonvalvular atrial fibrillation (AF) is a major cause of thromboembolic events. Compared to AF-related stroke, extracranial systemic embolic events (SEE) remain poorly defined.

Triple therapy has similar outcomes, more bleeding than dual therapy in older patients

05.08.20151404

Researchers analyzed 4,959 patients aged 65 years or older from the Acute Coronary Treatment and Intervention Outcomes Network Registry–Get With the Guidelines.

High CRP predicts long-term mortality, MI after PCI

04.08.20151549

Higher levels of C-reactive protein at the time of PCI were predictive of all-cause mortality and MI at 10 years, researchers reported in a new study.

Enrollment begins for two trials of dabigatran

03.08.20151422

The first U.S. patients have been enrolled in the RE-DUAL PCI and RE-CIRCUIT trials of the safety and efficacy of dabigatran in patients with nonvalvular atrial fibrillation, according to a press release from Boehringer Ingelheim.

Edoxaban versus placebo, aspirin, or aspirin plus clopidogrel for stroke prevention in atrial fibrillation

31.07.20151553

As non-valvular atrial fibrillation (AF) brings a risk of stroke, oral anticoagulants (OAC) are recommended.

Arrhythmic Mitral Valve Prolapse and Sudden Cardiac Death

30.07.20151463

Mitral valve prolapse (MVP) may present with ventricular arrhythmias and sudden cardiac death (SCD) even in the absence of hemodynamic impairment.

Association of prior beta-blocker use and the outcomes of patients with out-of-hospital cardiac arrest

29.07.20151341

Beta-blocker therapy is one of the most commonly prescribed treatments for patients with cardiac conditions. In patients with out-of-hospital cardiac arrest (OHCA) however, recent data suggest prior treatment with beta-blockers could be harmful by lowering the incidence of a shockable presenting rhythm.